arrow
P

Przemysława Jarosz-Chobot

Medical University of Silesia
H指数:34
被引数:5,672

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration

通过改善调节性T细胞抑制活性,PD-1受体 () t细胞与调节性t细胞和利妥昔单抗联合治疗1型糖尿病儿童的疗效相关

2024-05-010
PRE
Age-period-cohort modelling of type 1 diabetes incidence rates among children included in the EURODIAB 25-year follow-up study

EURODIAB 25年随访研究中儿童1型糖尿病发病率的年龄周期队列模型

2022-10-075
OA
Diabetic ketoacidosis incidence among children with new-onset type 1 diabetes in Poland and its association with COVID-19 outbreak-Two-year cross-sectional national observation by PolPeDiab Study Group

波兰新发1型糖尿病儿童的糖尿病酮症酸中毒发生率及其与新型冠状病毒肺炎暴发的关系-PolPeDiab研究组为期两年的横断面全国观察

2022-07-0411
OA
Combined therapy with CD4+CD25highCD127-T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy: Randomized phase I/II trial

CD4 CD25highCD127-T调节细胞和anti-CD20抗体联合治疗新发1型糖尿病优于单药治疗: 随机I/II期试验

2022-05-0926
PRE
Next- generation sequencing is an effective method for diagnosing patients with different forms of monogenic diabetes
2022-01-0113
PRE
Above 40% of Polish children and young adults with type 1 diabetes achieve international HbA1c target - results of a nationwide cross-sectional evaluation of glycemic control: The PolPeDiab HbA1c study
2021-08-048
OAAI